Glenmark Life Sciences Limited

BSE:543322 Stock Report

Mkt Cap: ₹47.9b

Glenmark Life Sciences Past Performance

How has Glenmark Life Sciences performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


26.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 543322 has high quality earnings.

Growing Profit Margin: 543322's current net profit margins (20.5%) are higher than last year (20.2%).


Past Earnings Growth Analysis

Earnings Trend: 543322's earnings have grown significantly by 26.6% per year over the past 5 years.

Accelerating Growth: 543322's earnings growth over the past year (1%) is below its 5-year average (26.6% per year).

Earnings vs Industry: 543322 earnings growth over the past year (1%) exceeded the Pharmaceuticals industry -15.6%.


Return on Equity

High ROE: 543322's Return on Equity (19.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies